buparlisib   Click here for help

GtoPdb Ligand ID: 7878

Synonyms: BKM 120 | BKM-120 | BKM120 | NVP-BKM120
PDB Ligand
Compound class: Synthetic organic
Comment: The discovery of buparlisib is described in [2] where it is compound 15. Buparlisib is a selective and orally bioavailable phosphoinositide 3-kinase (PI3K) inhibitor [2-3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 89.63
Molecular weight 410.17
XLogP 2.66
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Nc1ncc(c(c1)C(F)(F)F)c1cc(nc(n1)N1CCOCC1)N1CCOCC1
Isomeric SMILES Nc1ncc(c(c1)C(F)(F)F)c1cc(nc(n1)N1CCOCC1)N1CCOCC1
InChI InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)
InChI Key CWHUFRVAEUJCEF-UHFFFAOYSA-N
Bioactivity Comments
Surface plasmon resonance (SPR) analysis of target residence time (τ) reported by Willemsen-Seegers et al. (2016) confirms the pan-PI3K profile of buparlisib as evaluated by IC50 analysis in kinase assays [4]. At high concentration (> 1 μmol/L) buparlisib has off-target activity, by directly binding to tubulin, inhibiting microtubule dynamics which causes cell cycle arrest [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha Primary target of this compound Hs Inhibitor Inhibition 7.5 pIC50 - 2
pIC50 7.5 (IC50 3x10-8 M) [2]